Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.
Bressler
N M
NM
Retinal Vascular Center, Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2010, USA. pstaflin@jhmi.edu
Bressler
S B
SB
D000818:Animals; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D005654:Fundus Oculi; D006801:Humans; D008268:Macular Degeneration / Q000150:complications; D009885:Ophthalmology / Q000639:trends; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D000077362:Verteporfin; D014786:Vision Disorders / Q000517:prevention & control
D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin